New Study Finds Limited Value From Nearly One-Third of Clinical Trial Procedures and Associated Data, Highlighting Opportunity for More Patient-Centric Trial Design PHILADELPHIA, Sept. 15, 2025 /PRNewswire/ — TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated […]
New Study Finds Limited Value From Nearly One-Third of Clinical Trial Procedures and Associated Data, Highlighting Opportunity for More Patient-Centric Trial Design PHILADELPHIA, Sept. 15, 2025 /PRNewswire/ — TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated […]
